[1] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell,2007,131:861-872.
[2] Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology,2010,51:297-305.
[3] Baxter M, Withey S, Harrison S, et al. Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol,2015,62:581-589.
[4] Fourrier A, Delbos F, Menoret S, et al. Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells. Xenotransplantation,2020,27:e12544.
[5] Lawton BR, Sosa JA, Roman S, et al. Effect of a matrigel sandwich on endodermal differentiation of human embryonic stem cells. Stem Cell Rev Rep,2013,9:578-585.
[6] Freyer N, Greuel S, Kn?spel F, et al. Effects of Co-Culture Media on Hepatic Differentiation of hiPSC with or without HUVEC Co-Culture. Int J Mol Sci,2017,18:1724.
[7] Pettinato G, Ramanathan R, Fisher RA, et al. Scalable Differentiation of Human iPSCs in a Multicellular Spheroid-based 3D Culture into Hepatocyte-like Cells through Direct Wnt/β-catenin Pathway Inhibition. Sci Rep,2016,6:32888.
[8] Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science,2014,345:1247125.
[9] Takebe T, Sekine K, Kimura M, et al. Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells. Cell Rep,2017,21:2661-2670.
[10] Bishop ES, Mostafa S, Pakvasa M, et al. 3-D bioprinting technologies in tissue engineering and regenerative medicine: Current and future trends. Genes Dis, 2017,4:185-195.
[11] Ma X, Qu X, Zhu W, et al. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc Natl Acad Sci U S A,2016,113:2206-2211.
[12] Wang Y, Wang H, Deng P, et al. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip, 2018,18:3606-3616.
[13] Song W, Lu YC, Frankel AS, et al. Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation. Sci Rep,2015,5:16884.
[14] Sampaziotis F, de Brito MC, Madrigal P, et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol, 2015,33:845-852.
[15] Jaramillo M, Yeh H, Yarmush ML, et al. Decellularized human liver extracellular matrix (hDLM)-mediated hepatic differentiation of human induced pluripotent stem cells hIPSCs. J Tissue Eng Regen Med,2018,12:e1962-e1973.
[16] Takeishi K, Collin de l'Hortet A, Wang Y, et al. Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells. Cell Rep,2020,31:107711.
[17] Wang S, Wang X, Tan Z, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res,2019,29:1009-1026.
[18] de Almeida PE, Meyer EH, Kooreman NG, et al. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun,2014,5:3903.
[19] Liu X, Li W, Fu X, et al. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives. Front Immunol,2017,8:645. |
